Furosemide Other names: Frusemide

Chemical formula: C₁₂H₁₁ClN₂O₅S  Molecular mass: 330.744 g/mol  PubChem compound: 3440

Therapeutic indications

Furosemide is indicated for:

Pulmonary oedema

Population group: only adults (18 years old or older)

Pulmonary edema

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Oedema

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

The treatment of oedema associated with congestive heart failure, cirrhosis of the liver, renal disease including nephrotic syndrome.

The treatment of peripheral oedema due to mechanical obstruction, venous insufficiency, mild to moderate hypertension.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Oedema

Population group: only infants (40 days - 1 year old) , children (1 year - 12 years old) , adolescents (12 years - 18 years old)

The treatment of oedema associated with congestive heart failure, cirrhosis of the liver, renal disease including nephrotic syndrome.

The treatment of peripheral oedema due to mechanical obstruction, venous insufficiency, mild to moderate hypertension.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Hypertension

Population group: only adults (18 years old or older)

Hypertension

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Pulmonary oedema

Population group: only infants (40 days - 1 year old) , children (1 year - 12 years old)

Pulmonary edema

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Furosemide is contraindicated in the following cases:

Lactation

Lactation

Digitalis intoxication

Poisoning caused by Digitalis glycoside

Porphyria

Porphyria

Impaired renal function with a creatinine clearance below 30ml/min per 1.73 m² body surface area

at least one of

Renal failure stage 5: Kidney failure (GFR <15 mL/min/1.73 m2 or dialysis)

Renal failure associated with hepatic coma

Hepatic coma and additionally Renal failure

Severe hypokalaemia

Hypokalemia

Severe hyponatraemia

Hyponatremia

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2018: FUROSEMIDE TABLETS BP Uncoated tablet
Summary of Product Characteristics (SPC) 2018: FUROSEMIDE Solution for injection
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈